The Pharma Data

AUGUST 19, 2021

Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company’s commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. today announced U.S.

FDA Approval 52

FDA Approval DNA Reagent Protein 52

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

The Pharma Data

JANUARY 27, 2021

Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. I look forward to updating the market when we have definitive clinical performance data.”. 28, 2021 09:19 UTC.

Reagent 52

Reagent In-Vitro FDA Approval Development 52

Pharmaceutical Technology

APRIL 28, 2023

Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

Drug Discovery World

DECEMBER 13, 2023

Fortis Life Sciences offers custom antibody discovery and manufacturing services for antibodies and single-domain antibodies, supporting the drug discovery market. Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics. View all of our offerings for the therapeutics and diagnostics markets.

Life Science 59

Life Science Antibody Manufacturing In-Vivo 59